Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine
暂无分享,去创建一个
Paul Chenoweth | Roland W Sutter | N. Grassly | I. Blake | N. Molodecky | R. Sutter | A. Bandyopadhyay | O. Diop | M. Pons-Salort | P. Chenoweth | M. Zaffran | Isobel M Blake | Ousmane M Diop | Ananda S Bandyopadhyay | Nicholas C Grassly | Michel Zaffran | Margarita Pons-Salort | Natalie A Molodecky
[1] Qi Chen,et al. Vaccine-Derived Poliovirus Outbreaks and Events — Three Provinces, Democratic Republic of the Congo, 2017 , 2018, MMWR. Morbidity and mortality weekly report.
[2] Hil M. Lyons,et al. Evaluating cessation of the type 2 oral polio vaccine by modeling pre- and post-cessation detection rates. , 2017, Vaccine.
[3] Michael Famulare,et al. The risk of type 2 oral polio vaccine use in post-cessation outbreak response , 2017, BMC Medicine.
[4] N. Grassly,et al. Risk factors and short-term projections for serotype-1 poliomyelitis incidence in Pakistan: A spatiotemporal analysis , 2017, PLoS medicine.
[5] O. Diop,et al. Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016 — Worldwide, 2016–2017 , 2017, MMWR. Morbidity and mortality weekly report.
[6] R. Nielsen,et al. The Evolutionary Pathway to Virulence of an RNA Virus , 2017, Cell.
[7] Update on vaccine-derived polioviruses worldwide, January 2016–June 2017. , 2017, Releve epidemiologique hebdomadaire.
[8] Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data , 2016, PLoS medicine.
[9] L. Hampton,et al. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016. , 2016, MMWR. Morbidity and mortality weekly report.
[10] N. Grassly,et al. Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame , 2016, PLoS pathogens.
[11] S. Tegegne,et al. Contribution of Environmental Surveillance Toward Interruption of Poliovirus Transmission in Nigeria, 2012–2015 , 2016, The Journal of infectious diseases.
[12] Paul Chenoweth,et al. Faster Detection of Poliomyelitis Outbreaks to Support Polio Eradication , 2016, Emerging infectious diseases.
[13] F. Shuaib,et al. Environmental isolation of circulating vaccine-derived poliovirus after interruption of wild poliovirus transmission, Nigeria, 2016. , 2016, Releve epidemiologique hebdomadaire.
[14] Stewart T. Chang,et al. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria , 2015, Journal of Virology.
[15] J. Meschke,et al. Development of a novel bag-mediated filtration system for environmental recovery of poliovirus. , 2014, Journal of water and health.
[16] K. Thompson,et al. Modeling the dynamics of oral poliovirus vaccine cessation. , 2014, The Journal of infectious diseases.
[17] S. Lowther,et al. Environmental surveillance for polioviruses in the Global Polio Eradication Initiative. , 2014, The Journal of infectious diseases.
[18] Roland W Sutter,et al. The new polio eradication end game: rationale and supporting evidence. , 2014, The Journal of infectious diseases.
[19] A. Levitt,et al. Surveillance Systems to Track Progress Toward Global Polio Eradication — Worldwide, 2012–2013 , 2014, MMWR. Morbidity and mortality weekly report.
[20] Meeting of the Strategic Advisory Group of Experts on Immunization, November 2012 – conclusions and recommendations. , 2013, Releve epidemiologique hebdomadaire.
[21] N. Grassly,et al. Waning intestinal immunity after vaccination with oral poliovirus vaccines in India. , 2012, The Journal of infectious diseases.
[22] A. Tatem,et al. Population Distribution, Settlement Patterns and Accessibility across Africa in 2010 , 2012, PloS one.
[23] Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011. , 2011, MMWR. Morbidity and mortality weekly report.
[24] WatanabeSumio. Asymptotic Equivalence of Bayes Cross Validation and Widely Applicable Information Criterion in Singular Learning Theory , 2010 .
[25] N. Grassly,et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case-control study , 2007, The Lancet.
[26] Frank Fenner,et al. Public health. Is polio eradication realistic? , 2006, Science.
[27] M. Pallansch,et al. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. , 2005, Annual review of microbiology.
[28] M. Pallansch,et al. Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand , 2005, The Lancet.
[29] M. Pallansch,et al. Vaccine policy changes and epidemiology of poliomyelitis in the United States. , 2004, JAMA.
[30] D. Heymann,et al. Eradicating polio. , 2004, The New England journal of medicine.
[31] Apparent global interruption of wild poliovirus type 2 transmission. , 2001, MMWR. Morbidity and mortality weekly report.
[32] Francis Tuerlinckx,et al. Diagnostic checks for discrete data regression models using posterior predictive simulations , 2000 .